Pharmacologic and endocrine aspects of carcinoid syndrome.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001920:Bradykinin / Q000096:biosynthesis; D002247:Carbon Isotopes; D002276:Carcinoid Tumor / Q000145:classification / Q000150:complications / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D002318:Cardiovascular Diseases / Q000150:complications; D002395:Catecholamines; D002838:Chromaffin System / Q000503:physiopathology; D004890:Erythema / Q000139:chemically induced; D005769:Gastrointestinal Motility / Q000187:drug effects; D006632:Histamine / Q000652:urine; D006801:Humans; D006811:Humerus; D007211:Indoles / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology; D009369:Neoplasms; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology; D012702:Serotonin Antagonists
D002247:Carbon Isotopes; D002395:Catecholamines; D007211:Indoles; D012702:Serotonin Antagonists; D012701:Serotonin; D006632:Histamine; D000324:Adrenocorticotropic Hormone; D001920:Bradykinin